Evidence map›Paper›PMID 41935989›Full record

ArticleWorld journal of urology2026

An online decision aid for patients with prostate cancer evaluating local treatment options reduces decisional conflict and distress and improves knowledge: Postmarket surveillance in German routine care.

Philipp Karschuck, Tobias Kessler, Philipp Reimold, Luka Flegar, Gita Schönberg, Paul Schneider, Andreas Ihrig, Tanja Krones, Marco Knöll, Elke Kessler and 4 more

Abstract read
In one paragraph

Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Philipp KarschuckDepartment of Urology, Heidelberg University Hospital, Im Neuenheimer Feld 420, DE-69120, Heidelberg, Germany. philipp.karschuck@med.uni-heidelberg.de.
Tobias KesslerNeurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Philipp ReimoldDepartment of Urology, Heidelberg University Hospital, Im Neuenheimer Feld 420, DE-69120, Heidelberg, Germany.
Luka FlegarDepartment of Urology, Heidelberg University Hospital, Im Neuenheimer Feld 420, DE-69120, Heidelberg, Germany.
Gita SchönbergDepartment of Urology, Heidelberg University Hospital, Im Neuenheimer Feld 420, DE-69120, Heidelberg, Germany.
Paul SchneiderDepartment of Urology, Heidelberg University Hospital, Im Neuenheimer Feld 420, DE-69120, Heidelberg, Germany.
Andreas IhrigDepartment of General Internal Medicine and Psychosomatic, Division of Psychooncology, University of Heidelberg, Heidelberg, Germany.
Tanja KronesInstitute of Biomedical Ethics and History of Medicine, University Hospital Zurich, Zurich, Switzerland.
Marco KnöllASD Concepts GmbH & Co. KG, Institute for Patient-Centred Methods of Care, Reinheim, Germany.
Elke KesslerASD Concepts GmbH & Co. KG, Institute for Patient-Centred Methods of Care, Reinheim, Germany.
Christian WülfingDepartment of Urology, Asklepios Klinik Altona, Hamburg, Germany.
Maurice Stephan MichelDepartment of Urology and Urosurgery, University Hospital Mannheim, Mannheim, Germany.
Christer GroebenDepartment of Urology, Heidelberg University Hospital, Im Neuenheimer Feld 420, DE-69120, Heidelberg, Germany.
Johannes HuberDepartment of Urology, Heidelberg University Hospital, Im Neuenheimer Feld 420, DE-69120, Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveSince 2016, more than 26,000 patients have used the online prostate cancer (PC) decision aid “Entscheidungshilfe Prostatakrebs”. Because a large, randomized, controlled evaluation trial failed to show effects regarding the primary and secondary outcomes after 4 weeks, we used postmarket surveillance data for further analyses. The aim of this study was to analyze the immediate effects of using a PC decision aid on decisional conflict, distress, and knowledge.

methodsA total of 2,245 patients used the PC decision aid between 05/2023 and 01/2024. We applied identical validated instruments before and after use to record immediate effects in an intra-individual comparison; the endpoints were decisional conflict (Decisional Conflict Scale, DCS), distress (Distress Thermometer), and objective knowledge (Decision Quality Worksheet).

resultsComplete data were available for 880 patients (39.2%). The mean patient age was 66.3 ± 7.2 (range 43–84) years. The DCS score improved from 37.5 ± 23.7 before to 20.1 ± 15.7 after using the decision aid (p < 0.001). This effect was consistent across all the DCS subscales: level of information, clarity, support, and uncertainty. The Distress Thermometer (0: no distress; to 10: maximum distress) showed an improvement of 3.1 points from 6.2 ± 2.6 to 3.1 ± 2.6 (p < 0.001). Objective knowledge significantly improved for 4 out of the 5 questions, with differences in absolute percentages of correct answers ranging from 18.8% to 30%. The number of correct answers before vs. after using the PC decision aid increased from 2.3 ± 1.1 to 3.0 ± 1.1 (p < 0.001).

conclusionIn conjunction with the results of our previous work, we can now report strong immediate effects that diminish over a period of four weeks: the evaluated online PC decision aid reduces decisional conflict and distress and improves patient knowledge. These results provide further support for offering this tool to all suitable patients. An ongoing randomized controlled study will address the current study limitations.

Indexed as

Conflict, PsychologicalDecision MakingDecision Support TechniquesHealth Knowledge, Attitudes, PracticeProstatic NeoplasmsPsychological DistressAdultAgedAged, 80 and overGermanyHumansInternetMaleMiddle AgedProduct Surveillance, PostmarketingDecision aidHealth services researchPostmarket surveillanceProstate cancerShared decision-making

Identifiers

PMID41935989
PMCPMC13050760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.